Company
Gain Therapeutics, Inc. (GANX)
Standardized SEC financial data for Gain Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001819411 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-60.6%
Return on equity
-108.6%
Free cash flow
-$18.5M
Debt / equity
0.03×
Current ratio
6.63×
EPS (diluted)
$-0.61
Ratios for fiscal year 2023, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $29K | $165K | $140K | $55K | — | — |
| R&D expense |
Balance sheet
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $36.9M | $7.3M | $16.8M | $10.4M | $20.9M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$3.2M | -$12.4M | -$14.7M | -$18.9M | -$18.9M | -$18.5M |
| Capital expenditures |
Get GANX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/GANX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/GANX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"